Despite high rates of anxiety and depression among adults with ASD, treatment methods for these comorbid conditions have not been systematically studies or compared in this patient population. Recently, MBSR and CBT protocols were adapted for adults…
ID
Bron
Aandoening
autism, cognitive behavioral therapy, mindfulness based stress reduction
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
reduction on anxiety scale and the depression scale of the hospital anxiety and depression scale (HADS)
Achtergrond van het onderzoek
A three-arm RCT among 180 adults with ASD (60 MBSR, 60 CBT, and 60 treatment as usual, (TAU)), conducted in an outpatient setting with measurements at the start and end of the 13 week treatment period, and at 3 months follow-up. Instruments include the hospital anxiety and depressions scale, rumination, irrational belief and mindfulness scales, and an autism symptom checklist
Doel van het onderzoek
Despite high rates of anxiety and depression among adults with ASD, treatment methods for these comorbid conditions have not been systematically studies or compared in this patient population. Recently, MBSR and CBT protocols were adapted for adults with ASD and could be excellent candidate therapies for reducing anxiety and depression.
The study looks at the ability of both treatment methods to reduce anxiety and depression symptoms among adults with ASD, and to determine which therapy is best suited for which patient.
Onderzoeksopzet
in each cycle:
Mo: at intake
M1: at start of the 13 week treatment period
M1a: after 4 weeks treatment
M1b: after 8 weeks treatment
M2: on completion of 13 week treatment period
M3: at 3 months follow up
Onderzoeksproduct en/of interventie
1. cognitive behavioral therapy addopted for adults with ASD (Schuurman, 2012) over a 13 week period
2. Mindfullness based stress reduction therapy for adults with ASD (Spek, 2012) over a 13 week period
3. Treatment as ususal
Publiek
PO box 5003
B. Sizoo
Deventer 7416 SB
The Netherlands
+31 575 639 652
b.sizoo@dimence.nl
Wetenschappelijk
PO box 5003
B. Sizoo
Deventer 7416 SB
The Netherlands
+31 575 639 652
b.sizoo@dimence.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. adults with a clinical diagnosis of ADHD
2. normally intelligent
3. able to do homework assignments associated with treatment
4. score of > 8 on hospital anxiety and depression scale (HADS)
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
- former treatment with mindfulness or cognitive behavioral therapy for adults with autism
- too sensitive for group treatment
- psychosis or under influence of alcohol or drugs
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL4082 |
NTR-old | NTR4233 |
CCMO | NL40743.072.12 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |
OMON | NL-OMON36888 |